The ABPI broadly welcomes Health Secretary Jeremy Hunt's proposal to publish indicative medicines cost to the NHS on packs of all medicines costing more than £20.Read more
The ABPI welcomes today’s publication of the National Institute of Health and Care Excellence (NICE) draft multiple technology appraisal (MTA) appraisal consultation document for rheumatoid arthritis which provisionally recommends continued access to biologic medicines for patients living with severe rheumatoid arthritis.Read more
The ABPI welcomes the focus on medicines optimisation within the interim report of the Carter Review, which was published by the Department of Health yesterday.Read more
The ABPI and the Department of Health have today announced a payment of £207 million from industry to underwrite growth of the medicines bill for the first quarter of 2015 under the 2014 Pharmaceutical Price Regulation Scheme (PPRS).Read more
Our website is not compatible with Internet Explorer 8. If you are experiencing problems with scrolling please upgrade to a later version or use another browser.